HomeComparePOLBF vs KMB

POLBF vs KMB: Dividend Comparison 2026

POLBF yields 3344.48% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 POLBF wins by $1284463355857.06M in total portfolio value
10 years
POLBF
POLBF
● Live price
3344.48%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1284463355857.10M
Annual income
$1,213,110,815,498,324,000.00
Full POLBF calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — POLBF vs KMB

📍 POLBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPOLBFKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, POLBF + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
POLBF pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

POLBF
Annual income on $10K today (after 15% tax)
$284,280.94/yr
After 10yr DRIP, annual income (after tax)
$1,031,144,193,173,575,300.00/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, POLBF beats the other by $1,031,144,193,173,570,800.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of POLBF + KMB for your $10,000?

POLBF: 50%KMB: 50%
100% KMB50/50100% POLBF
Portfolio after 10yr
$642231677928.57M
Annual income
$606,555,407,749,164,500.00/yr
Blended yield
94.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

POLBF
No analyst data
Altman Z
39.8
Piotroski
1/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

POLBF buys
0
KMB buys
0
No recent congressional trades found for POLBF or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPOLBFKMB
Forward yield3344.48%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$1284463355857.10M$45.9K
Annual income after 10y$1,213,110,815,498,324,000.00$5,222.34
Total dividends collected$1279557275592.29M$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: POLBF vs KMB ($10,000, DRIP)

YearPOLBF PortfolioPOLBF Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$345,148$334,448.16$11,314$614.45+$333.8KPOLBF
2$11,157,548$10,788,239.94$12,867$760.19+$11.14MPOLBF
3$337,872,856$325,934,279.31$14,713$945.27+$337.86MPOLBF
4$9,585,767,941$9,224,243,985.35$16,924$1,181.90+$9585.75MPOLBF
5$254,836,586,625$244,579,814,927.95$19,596$1,486.64+$254836.57MPOLBF
6$6,349,429,806,239$6,076,754,658,549.98$22,850$1,882.16+$6349429.78MPOLBF
7$148,295,333,941,378$141,501,444,048,701.88$26,849$2,399.80+$148295333.91MPOLBF
8$3,247,334,232,557,481$3,088,658,225,240,206.50$31,812$3,083.36+$3247334232.53MPOLBF
9$66,684,617,157,738,690$63,209,969,528,902,180.00$38,033$3,994.72+$66684617157.70MPOLBF
10$1,284,463,355,857,104,100$1,213,110,815,498,324,000.00$45,918$5,222.34+$1284463355857.06MPOLBF

POLBF vs KMB: Complete Analysis 2026

POLBFStock

Poolbeg Pharma plc operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an in­licensed first­in­class intranasally administered RNA­based immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis. The company also has a licensed access to micro­ and nanoencapsulation technology to develop an oral vaccine delivery platform that delivers immune stimulating antigens to various areas of the gut; and artificial intelligence powered drug program. In addition, it is involved in the development of biomarker platform to identify those at risk of developing severe disease; and vaccine discovery platform, a model-derived discovery platform to identify new vaccine candidates. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.

Full POLBF Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this POLBF vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

POLBF vs SCHDPOLBF vs JEPIPOLBF vs OPOLBF vs KOPOLBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.